on B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520)
BRAIN Biotech AG Names Dr. Sven K. Weber as CEO
BRAIN Biotech AG has announced the appointment of Dr. Sven K. Weber as the new Chairman of the Executive Board. This change will take effect on October 1, 2026. Dr. Weber, who is 44 years old, is transitioning from BASF SE where he held various management roles since 2011. His term as CEO will span three years. Dr. Weber will be succeeding Adriaan Moelker, who is retiring after over six years at the helm of BRAIN Biotech AG.
Located in Zwingenberg, Germany, BRAIN Biotech AG operates in the biotechnology industry. This announcement was made by the company's Supervisory Board as a strategic leadership change. Adriaan Moelker's tenure was marked by notable achievements, and Dr. Weber is expected to continue the company's trajectory in innovation and growth.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all B.R.A.I.N. Biotechnology Research And Information Network AG news